Publication: Do Polymorphisms at the CD14 Promoter Gene and Soluble CD14 Levels Effect Biological Response to IFN Beta Therapy in Multiple Sclerosis?
| dc.contributor.author | Asli, Kurne | |
| dc.contributor.author | Guliz, Sayat | |
| dc.contributor.author | Cansin, Sackesen | |
| dc.contributor.author | Esra, Birben | |
| dc.contributor.author | faruk, Aydin Omer | |
| dc.contributor.author | Murat, Terzi | |
| dc.contributor.author | Rana, Karabudak | |
| dc.date.accessioned | 2020-06-21T14:46:44Z | |
| dc.date.available | 2020-06-21T14:46:44Z | |
| dc.date.issued | 2010 | |
| dc.department | OMÜ | en_US |
| dc.department-temp | [Asli, Kurne -- Guliz, Sayat -- Rana, Karabudak] Hacettepe Univ, Dept Neurol, Ankara, Turkey -- [Cansin, Sackesen -- Esra, Birben] Hacettepe Univ, Pediat Allergy & Asthma Unit, Ankara, Turkey -- [faruk, Aydin Omer] 19 Mayis Univ, Pediat Neurol Dept, Samsun, Turkey -- [Murat, Terzi] 19 Mayis Univ, Dept Neurol, Samsun, Turkey | en_US |
| dc.description | 10th Congress of the International-Society-of-Neuroimmunology (ISNI) -- OCT 26-30, 2010 -- Sitges, SPAIN | en_US |
| dc.description.abstract | … | en_US |
| dc.description.sponsorship | Int Soc Neuroimmunol | en_US |
| dc.identifier.endpage | 28 | en_US |
| dc.identifier.issn | 0165-5728 | |
| dc.identifier.startpage | 28 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/17650 | |
| dc.identifier.volume | 228 | en_US |
| dc.identifier.wos | WOS:000283694400079 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Science BV | en_US |
| dc.relation.journal | Journal of Neuroimmunology | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Do Polymorphisms at the CD14 Promoter Gene and Soluble CD14 Levels Effect Biological Response to IFN Beta Therapy in Multiple Sclerosis? | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication |
